Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA grants approval for Qbrexza cloth as treatment of primary axillary hyperhidrosis

July 2, 2018

Introducing BioWorld Science: supporting R&D decisions through drug discovery and preclinical news

July 2, 2018

ZYDG-2, a GPR40 agonist for potential treatment of type 2 diabetes

July 2, 2018

Phase Ib data on intravenous dexmedetomidine support BioXcel's development of sublingual BXCL-501

July 2, 2018

Thinning out fat cells

July 2, 2018

Galapagos reports topline results for GLPG-2737, updates triple combination plans in cystic fibrosis

June 29, 2018

First-in-human results presented from VANCE study of ChAdOx1-MVA 5T4 vaccine

June 29, 2018

G1T38 demonstrates safety and early evidence of antitumor activity in breast cancer

June 29, 2018

Japan Tobacco and Torii Pharmaceutical discontinue development of JTS-661

June 29, 2018

Novartis to spin off Alcon eye care devices business

June 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...